X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3) 3
oncology (3) 3
aged (2) 2
aged, 80 and over (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
chemotherapy (2) 2
clinical-trial (2) 2
cost-benefit analysis (2) 2
cost-utility (2) 2
economics (2) 2
elderly patients (2) 2
erlotinib (2) 2
erlotinib hydrochloride (2) 2
gemcitabine (2) 2
humans (2) 2
lung neoplasms - drug therapy (2) 2
phase ii trial (2) 2
prospective studies (2) 2
quinazolines - therapeutic use (2) 2
vinorelbine (2) 2
2nd-line treatment (1) 1
age factors (1) 1
aged patients (1) 1
antineoplastic agents - economics (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - economics (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
cancer (1) 1
cancer research (1) 1
carcinoma, non-small-cell lung - economics (1) 1
care and treatment (1) 1
clinical trials (1) 1
comparative analysis (1) 1
costs and cost analysis (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
disease progression (1) 1
docetaxel (1) 1
docetaxel/gemcitabine (1) 1
dosage and administration (1) 1
economic aspects (1) 1
european-organization (1) 1
feasibility (1) 1
female (1) 1
frail elderly (1) 1
france (1) 1
genetics (1) 1
health care costs (1) 1
hematology, oncology and palliative medicine (1) 1
lung cancer, non-small cell (1) 1
lung cancer, small cell (1) 1
lung neoplasms - economics (1) 1
lung-cancer (1) 1
male (1) 1
medical care, cost of (1) 1
monte carlo method (1) 1
multicenter (1) 1
multivariate analysis (1) 1
neoplasms. tumors. oncology. including cancer and carcinogens (1) 1
non-small cell lung cancer (1) 1
nsclc (1) 1
oncology, experimental (1) 1
outcomes (1) 1
protein kinase inhibitors - therapeutic use (1) 1
pulmonary/respiratory (1) 1
qlq-c30 (1) 1
quality-adjusted life years (1) 1
questionnaire (1) 1
quinazolines - economics (1) 1
receptor, epidermal growth factor - antagonists & inhibitors (1) 1
research (1) 1
research article (1) 1
taxoids - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Cancer, ISSN 1471-2407, 07/2012, Volume 12, Issue 1, pp. 301 - 301
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 10/2019, Volume 25, Issue 19, pp. 5759 - 5765
Purpose: The IFCT-GFPC-0701 MAPS phase III trial highlighted significant improvement in overall survival from adding bevacizumab to the standard first-line... 
LUNG-CANCER | FEASIBILITY | ONCOLOGY | QLQ-C30 | EUROPEAN-ORGANIZATION | OUTCOMES | QUESTIONNAIRE | CHEMOTHERAPY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.